The Ozempic mass tort litigation has taken an unexpected turn with the passing of Judge Gene E.K. Pratter, a respected figure whose guidance was central to the case’s progress. Now reassigned to Judge Karen Marston, the transition raises questions about the case’s trajectory and its impact on the plaintiffs seeking justice.

Discover how this shift could shape the future of one of the most closely watched mass tort cases.

The NEC mass tort litigation has achieved a significant milestone with a $495 million settlement in St. Louis. Centered around claims involving necrotizing enterocolitis (NEC) in premature infants, this outcome marks a crucial step toward justice for affected families and reflects the gravity of the issues at stake.

Read more about the case, the settlement details, and what this means for the families involved.

The Hair Straightener Mass Tort, now centralized in the Northern District of Illinois, has seen a dramatic rise in lawsuits linking chemical hair straighteners to cancers like uterine and breast cancer. With over 8,300 cases filed and claims targeting major manufacturers, this litigation is shaping up to be a pivotal case in product liability law.

Read more to explore the allegations, key developments, and the potential impact of this expanding litigation.

The Zantac mass tort litigation continues to evolve, with recent court rulings on expert testimony and ongoing settlement negotiations playing pivotal roles. As claims linking the heartburn medication to cancer gain traction, both plaintiffs and pharmaceutical companies face mounting challenges in this landmark case.

Read more to uncover the latest developments and what they mean for the future of mass tort litigation.

A proposed class action lawsuit against Novo Nordisk claims that the risks of severe side effects, including stomach paralysis and gallbladder disease, were not adequately disclosed to patients and healthcare providers. With new studies linking Ozempic to serious gastrointestinal issues, the legal and medical scrutiny around the drug continues to grow.

Read more about the allegations, the lawsuit's implications, and what affected individuals should know about their legal rights.

The NEC litigation against major baby formula manufacturers like Abbott and Mead Johnson has reached a pivotal moment with a $60 million jury award. Focused on the risks of necrotizing enterocolitis in premature infants, these cases are setting the stage for future litigation within the growing multidistrict litigation.

Read more about the recent verdict, ongoing bellwether trials, and what this means for affected families.

The AFFF litigation concerning PFAS exposure, known as "forever chemicals," now includes over 7,700 personal injury lawsuits in South Carolina’s MDL. With bellwether trials on the horizon and billions already settled for water contamination, the focus now shifts to individual health claims linked to serious conditions like cancer.

Read more about the latest developments and what this could mean for affected individuals and communities.

The Talc mass tort litigation against Johnson & Johnson, involving over 53,000 lawsuits, faces a turning point with a proposed $6.48 billion settlement to resolve ovarian cancer claims. With ongoing trials and scientific debates over asbestos in talcum powder, the future of this high-profile case remains uncertain.

Read more about the settlement proposal, legal challenges, and what’s next in this landmark litigation.

The Bard PowerPort, designed to simplify medical procedures, has become the center of controversy due to severe complications, including infections and device failures. With over 70 lawsuits consolidated into an MDL, plaintiffs allege that the device’s defects and Bard’s failure to act have caused life-altering injuries.

Read more about the unfolding litigation, the risks of the device, and what affected patients need to know.